KOTLER KEVIN
13F Reported Value
ⓘ$427.5M
incl. option notional
Equity Holdings
ⓘ$135.4M
Option Notional
ⓘ$292.1M
$269.4M puts / $22.7M calls
Holdings
38
Latest Filing
2025-12-31
Filing Quarter
Q4 2025
Portfolio Overview
KOTLER KEVIN disclosed 38 positions worth $427.5M in its Form 13F-HR for Q4 2025 — $135.4M in common stock plus $292.1M of put/call option positions (reported at underlying notional value, not premium at risk), led by $SPY (SPDR S&P 500 ETF TRUST) puts, followed by $QQQ and $ANGO. During the quarter the fund opened 38 new positions and exited 0 — including a new stake in $SPY. The portfolio is most concentrated in Healthcare (91.5% of disclosed assets). All figures are sourced directly from KOTLER KEVIN’s Form 13F-HR filing with the SEC under CIK 1601692.
Sector Allocation
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q4 2025
Click any card to unlockTop Holdings
- —
Quality
$238.7M350,000 sh - $30.7M50,000 sh
- 26.9#2,498
Quality
$22.0M1,713,789 sh - 73.3
Quality
$19.5M1,224,846 sh - $19.0M879,400 sh
- —
Quality
$16.0M741,343 sh - —
Quality
$15.6M905,635 sh - 30.5
Quality
$9.7M631,468 sh - —
Quality
$6.2M337,236 sh - 38.0
Quality
$5.5M168,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 SPDR S&P 500 ETF TRUST$SPYPUT | — | $238.7M | 350,000 |
 INVESCO QQQ TRUST, SERIES 1$QQQPUT | — | $30.7M | 50,000 |
 ANGIODYNAMICS INC$ANGO | 26.9#2,498 | $22.0M | 1,713,789 |
 Aurinia Pharmaceuticals Inc.$AUPH | 73.3 | $19.5M | 1,224,846 |
 AVADEL PHARMACEUTICALS PLC$AVDLCALL | — | $19.0M | 879,400 |
| AVADEL PHARMACEUTICALS PLC$AVDL | — | $16.0M | 741,343 |
 OMEROS CORP$OMER | — | $15.6M | 905,635 |
 NeuroPace Inc$NPCE | 30.5 | $9.7M | 631,468 |
 MediWound Ltd.$MDWD | — | $6.2M | 337,236 |
 Axogen, Inc.$AXGN | 38.0 | $5.5M | 168,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of KOTLER KEVIN's 38 positions.
Showing top 10 of 38 holdings.
Sector Allocation
Healthcare
$123.9M
Industrials
$5.0M
Other
$3.2M
Consumer Discretionary
$2.3M
Technology
$452,188
Energy
$355,133
Financials
$241,560
Full Holdings — KOTLER KEVIN (Q4 2025)
All 38 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $SPYPUT | SPDR S&P 500 ETF TRUST | $238.7M | — | NEW | — |
| 2 | $QQQPUT | INVESCO QQQ TRUST, SERIES 1 | $30.7M | — | NEW | — |
| 3 | $ANGO | ANGIODYNAMICS INC | $22.0M | 16.3% | NEW | 26.9 |
| 4 | $AUPH | Aurinia Pharmaceuticals Inc. | $19.5M | 14.4% | NEW | 73.3 |
| 5 | $AVDLCALL | AVADEL PHARMACEUTICALS PLC | $19.0M | — | NEW | — |
| 6 | $AVDL | AVADEL PHARMACEUTICALS PLC | $16.0M | 11.8% | NEW | — |
| 7 | $OMER | OMEROS CORP | $15.6M | 11.5% | NEW | — |
| 8 | $NPCE | NeuroPace Inc | $9.7M | 7.2% | NEW | 30.5 |
| 9 | $MDWD | MediWound Ltd. | $6.2M | 4.6% | NEW | — |
| 10 | $AXGN | Axogen, Inc. | $5.5M | 4.1% | NEW | 38 |
| 11 |  $IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $5.3M | 3.9% | NEW | 31.7 |
| 12 |  $ACRS | Aclaris Therapeutics, Inc. | $5.1M | 3.8% | NEW | 9.2 |
| 13 |  $EVTL | Vertical Aerospace Ltd. | $5.0M | 3.7% | NEW | — |
| 14 |  $OSUR | ORASURE TECHNOLOGIES INC | $4.4M | 3.2% | NEW | 11.5 |
| 15 | $OMERCALL | OMEROS CORP | $3.8M | — | NEW | — |
| 16 | — | GALAPAGOS NV | $2.9M | 2.2% | NEW | — |
| 17 |  $LLY | ELI LILLY & Co | $2.1M | 1.6% | NEW | 89.3 |
| 18 |  $CERS | CERUS CORP | $2.1M | 1.5% | NEW | 29.3 |
| 19 |  $NKE | NIKE, Inc. | $2.0M | 1.5% | NEW | 53.4 |
| 20 |  $TECX | Tectonic Therapeutic, Inc. | $1.7M | 1.2% | NEW | — |
| 21 |  $CLYM | Climb Bio, Inc. | $1.6M | 1.2% | NEW | — |
| 22 |  $TMCI | TREACE MEDICAL CONCEPTS, INC. | $1.2M | 0.9% | NEW | 27.2 |
| 23 |  $TLSI | TriSalus Life Sciences, Inc. | $1.0M | 0.8% | NEW | 28.3 |
| 24 |  $DXCM | DEXCOM INC | $995,550 | 0.7% | NEW | 77.9 |
| 25 |  $VNDA | Vanda Pharmaceuticals Inc. | $882,000 | 0.7% | NEW | 24.8 |
| 26 |  $ALGN | ALIGN TECHNOLOGY INC | $680,658 | 0.5% | NEW | 58.2 |
| 27 |  $OKUR | OnKure Therapeutics, Inc. | $573,304 | 0.4% | NEW | — |
| 28 |  $GE | GENERAL ELECTRIC CO | $452,188 | 0.3% | NEW | 74.8 |
| 29 |  $LUNG | Pulmonx Corp | $442,000 | 0.3% | NEW | 23.9 |
| 30 |  $PTCT | PTC THERAPEUTICS, INC. | $379,800 | 0.3% | NEW | 80 |
| 31 |  $DY | DYCOM INDUSTRIES INC | $355,133 | 0.3% | NEW | 62.1 |
| 32 |  $TAK | TAKEDA PHARMACEUTICAL CO LTD | $311,800 | 0.2% | NEW | — |
| 33 |  $BBNX | Beta Bionics, Inc. | $250,342 | 0.2% | NEW | 22.8 |
| 34 | — | ISHARES TR | $242,509 | 0.2% | NEW | — |
| 35 |  $BAC | BANK OF AMERICA CORP /DE/ | $241,560 | 0.2% | NEW | 68.4 |
| 36 |  $AMZN | AMAZON COM INC | $230,820 | 0.2% | NEW | 74.6 |
| 37 |  $ELAN | Elanco Animal Health Inc | $205,299 | 0.1% | NEW | 52.2 |
| 38 |  $PLRX | PLIANT THERAPEUTICS, INC. | $113,460 | 0.1% | NEW | — |
New Positions (38)
$SPYPUT SPDR S&P 500 ETF TRUST$238.7M$QQQPUT INVESCO QQQ TRUST, SERIES 1$30.7M$ANGO ANGIODYNAMICS INC$22.0M$AUPH Aurinia Pharmaceuticals Inc.$19.5M$AVDLCALL AVADEL PHARMACEUTICALS PLC$19.0M$AVDL AVADEL PHARMACEUTICALS PLC$16.0M$OMER OMEROS CORP$15.6M$NPCE NeuroPace Inc$9.7M$MDWD MediWound Ltd.$6.2M$AXGN Axogen, Inc.$5.5M$IART INTEGRA LIFESCIENCES HOLDINGS CORP$5.3M$ACRS Aclaris Therapeutics, Inc.$5.1M$EVTL Vertical Aerospace Ltd.$5.0M$OSUR ORASURE TECHNOLOGIES INC$4.4M$OMERCALL OMEROS CORP$3.8MBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for KOTLER KEVIN including:
Track KOTLER KEVIN's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for KOTLER KEVIN and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: KOTLER KEVIN
13F Pro is an AI hedge fund tracker and stock research platform. For KOTLER KEVIN (SEC CIK: 1601692), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in KOTLER KEVIN's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.